Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
9.90
0.00 (0.00%)
Jul 21, 2026, 9:39 AM EDT - Market open
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of $343.9 million as of July 21, 2026. Its market cap has increased by 47.47% in one year.
Market Cap
343.90M
Enterprise Value
303.72M
1-Year Change
47.47%
Ranking
Category
Stock Price
$9.90
ChartMarket Cap Chart
Since December 31, 2004, Fennec Pharmaceuticals's market cap has increased from $65.80M to $343.90M, an increase of 422.64%. That is a compound annual growth rate of 7.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 343.90M | 58.84% |
| Dec 31, 2025 | 216.50M | 24.86% |
| Dec 31, 2024 | 173.40M | -41.97% |
| Dec 29, 2023 | 298.80M | 18.62% |
| Dec 30, 2022 | 251.90M | 120.19% |
| Dec 31, 2021 | 114.40M | -40.51% |
| Dec 31, 2020 | 192.30M | 48.95% |
| Dec 31, 2019 | 129.10M | 2.54% |
| Dec 31, 2018 | 125.90M | -20.82% |
| Dec 29, 2017 | 159.00M | 444.52% |
| Dec 30, 2016 | 29.20M | 53.68% |
| Dec 31, 2015 | 19.00M | -28.30% |
| Dec 31, 2014 | 26.50M | 208.14% |
| Dec 31, 2013 | 8.60M | -34.35% |
| Dec 31, 2012 | 13.10M | 61.73% |
| Dec 30, 2011 | 8.10M | -55.98% |
| Dec 31, 2010 | 18.40M | 260.78% |
| Dec 31, 2009 | 5.10M | - |
| Dec 31, 2008 | 5.10M | -85.26% |
| Dec 31, 2007 | 34.60M | 138.62% |
| Dec 29, 2006 | 14.50M | -51.67% |
| Dec 30, 2005 | 30.00M | -54.41% |
| Dec 31, 2004 | 65.80M | - |
| Dec 31, 2004 | 65.80M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 389.73M |
| Larimar Therapeutics | 386.22M |
| Autolus Therapeutics | 383.25M |
| Upstream Bio | 381.48M |
| Rocket Pharmaceuticals | 375.63M |
| Compass Therapeutics | 369.18M |
| Lexeo Therapeutics | 368.27M |
| Zentalis Pharmaceuticals | 363.76M |